EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 50 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $711,000 | -37.9% | 90,000 | -10.0% | 0.06% | -48.1% |
Q1 2017 | $1,145,000 | -42.2% | 100,000 | -41.2% | 0.11% | -57.1% |
Q4 2016 | $1,981,000 | -9.6% | 170,032 | +3.9% | 0.25% | +24.1% |
Q3 2016 | $2,191,000 | -23.0% | 163,638 | +13.9% | 0.20% | -41.2% |
Q2 2016 | $2,847,000 | +21.5% | 143,638 | +2.8% | 0.34% | +8.2% |
Q1 2016 | $2,343,000 | – | 139,688 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |